Clinical trial
A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis
NCT00002158 · Romark Laboratories L.C., Industry · Unknown status
Key facts
| NCT number | NCT00002158 |
|---|---|
| Title | A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis |
| Official title | Open-Label Compassionate Use of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients |
| Lead sponsor | Romark Laboratories L.C., Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Cryptosporidiosis, HIV Infections |
| Intervention type | Drug |
| Interventions | Nitazoxanide |
| First posted | Aug 31, 2001 |
| Last update posted | Jul 10, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: